---
figid: PMC12240100__gr2
figtitle: 'Canonical Wnt/Beta-catenin signaling pathwayCanonical Wnt/Beta-catenin
  signaling pathway: the Wnt/Beta-catenin pathway regulates cell proliferation, differentiation,
  and survival'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12240100
filename: gr2.jpg
figlink: /pmc/articles/PMC12240100/figure/F2/
number: F2
caption: 'Canonical Wnt/β-catenin signaling pathwayCanonical Wnt/β-catenin signaling
  pathway: the Wnt/β-catenin pathway regulates cell proliferation, differentiation,
  and survival. Inactive Wnt signaling promotes β-catenin degradation, preventing
  gene activation. Active Wnt signaling stabilizes β-catenin, allowing its nuclear
  translocation, where it binds to TCF/LEF transcription factors to activate genes
  like c-myc, cyclin D1, and CD44. This pathway is crucial in development, tissue
  homeostasis, and cancer progression'
papertitle: 'Recent advances in bladder cancer stem cells (BCSCs): A descriptive review
  of emerging therapeutic targets'
reftext: Shuai Li, et al. iScience. 2025 Jul 18;28(7).
year: '2025'
doi: 10.1016/j.isci.2025.112720
journal_title: iScience
journal_nlm_ta: iScience
publisher_name: Elsevier
keywords: Stem cells research | Cancer
automl_pathway: 0.9596351
figid_alias: PMC12240100__F2
figtype: Figure
redirect_from: /figures/PMC12240100__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12240100__gr2.html
  '@type': Dataset
  description: 'Canonical Wnt/β-catenin signaling pathwayCanonical Wnt/β-catenin signaling
    pathway: the Wnt/β-catenin pathway regulates cell proliferation, differentiation,
    and survival. Inactive Wnt signaling promotes β-catenin degradation, preventing
    gene activation. Active Wnt signaling stabilizes β-catenin, allowing its nuclear
    translocation, where it binds to TCF/LEF transcription factors to activate genes
    like c-myc, cyclin D1, and CD44. This pathway is crucial in development, tissue
    homeostasis, and cancer progression'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP5
  - LRP6
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - BTRC
  - CTNNB1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - GSK3A
  - GSK3B
  - APC
  - PROC
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - EP300
  - SMARCA4
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - TCF3
  - TCF7L1
  - MYC
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - CCND1
  - EGF
  - HNF4A
  - ALDH1A1
  - ALDH1A2
  - ALDH1A3
  - ALDH2
  - ALDH3A1
  - ALDH3A2
  - ALDH3B1
  - ALDH5A1
  - ALDH7A1
  - ALDH9A1
  - CD44
  - Nucleus
---
